Cargando…
First-line treatment of ovarian cancer: questions and controversies to address
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898654/ https://www.ncbi.nlm.nih.gov/pubmed/29662548 http://dx.doi.org/10.1177/1758835918768232 |
_version_ | 1783314160239509504 |
---|---|
author | Ledermann, Jonathan A. |
author_facet | Ledermann, Jonathan A. |
author_sort | Ledermann, Jonathan A. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5898654 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-58986542018-04-16 First-line treatment of ovarian cancer: questions and controversies to address Ledermann, Jonathan A. Ther Adv Med Oncol Editorial SAGE Publications 2018-04-11 /pmc/articles/PMC5898654/ /pubmed/29662548 http://dx.doi.org/10.1177/1758835918768232 Text en © The Author(s), 2018 http://www.creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Editorial Ledermann, Jonathan A. First-line treatment of ovarian cancer: questions and controversies to address |
title | First-line treatment of ovarian cancer: questions and controversies to address |
title_full | First-line treatment of ovarian cancer: questions and controversies to address |
title_fullStr | First-line treatment of ovarian cancer: questions and controversies to address |
title_full_unstemmed | First-line treatment of ovarian cancer: questions and controversies to address |
title_short | First-line treatment of ovarian cancer: questions and controversies to address |
title_sort | first-line treatment of ovarian cancer: questions and controversies to address |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898654/ https://www.ncbi.nlm.nih.gov/pubmed/29662548 http://dx.doi.org/10.1177/1758835918768232 |
work_keys_str_mv | AT ledermannjonathana firstlinetreatmentofovariancancerquestionsandcontroversiestoaddress |